{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T04:12:29Z","timestamp":1728101549816},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00108-024-01714-2","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T18:02:12Z","timestamp":1716400932000},"page":"1031-1035","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ungew\u00f6hnliche Progression einer Polycythaemia vera","Unusual progression of polycythemia vera"],"prefix":"10.1007","volume":"65","author":[{"given":"Philipp","family":"Lohneis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz-Wolfram","family":"Bernd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Czyborra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"1714_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.lrr.2019.03.004","volume":"11","author":"M Andrei","year":"2019","unstructured":"Andrei\u00a0M, Pandey\u00a0A, Avezbakiyev\u00a0B, Wang\u00a0JC (2019) Chronic myelomonocytic leukemia as a\u00a0transformation from polycythemia vera. Leuk Res Rep 11:14\u201316. https:\/\/doi.org\/10.1016\/j.lrr.2019.03.004","journal-title":"Leuk Res Rep"},{"key":"1714_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ajh.24740","volume":"92","author":"D Barraco","year":"2017","unstructured":"Barraco\u00a0D, Cerquozzi\u00a0S, Gangat\u00a0N et\u00a0al (2017) Monocytosis in polycythemia vera: Clinical and molecular correlates. Am J Hematol 92:640\u2013645. https:\/\/doi.org\/10.1002\/ajh.24740","journal-title":"Am J Hematol"},{"key":"1714_CR3","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1038\/bcj.2015.95","volume":"5","author":"S Cerquozzi","year":"2015","unstructured":"Cerquozzi\u00a0S, Tefferi\u00a0A (2015) Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a\u00a0literature review of incidence and risk factors. Blood Cancer\u00a0J 5:e366. https:\/\/doi.org\/10.1038\/bcj.2015.95","journal-title":"Blood Cancer J"},{"key":"1714_CR4","unstructured":"Editorial BoardWHO Classification of Tumours (2022) Haematolymphoid tumours [Internet; beta version im Druck]. Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/63.Lyon (France): International Agency for Research on Cancer;"},{"key":"1714_CR5","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1182\/blood-2004-09-3426","volume":"105","author":"G Finazzi","year":"2005","unstructured":"Finazzi\u00a0G, Caruso\u00a0V, Marchioli\u00a0R et\u00a0al (2005) Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a\u00a0prospective observational study. Blood 105:2664\u20132670. https:\/\/doi.org\/10.1182\/blood-2004-09-3426","journal-title":"Blood"},{"key":"1714_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.anndiagpath.2019.03.001","volume":"40","author":"JE Hidalgo-Lopez","year":"2019","unstructured":"Hidalgo-Lopez\u00a0JE, Kanagal-Shamanna\u00a0R, Reyes\u00a0S et\u00a0al (2019) Ring sideroblasts in chronic phase of polycythemia vera identifies a\u00a0subset of patients with an increased risk of progression to blast phase. Ann Diagn Pathol 40:45\u201348. https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.03.001","journal-title":"Ann Diagn Pathol"},{"key":"1714_CR7","first-page":"606","volume":"5","author":"RF Holcombe","year":"1991","unstructured":"Holcombe\u00a0RF, Treseler\u00a0PA, Rosenthal\u00a0DS (1991) Chronic myelomonocytic leukemia transformation in polycythemia vera. Leukemia 5:606\u2013610","journal-title":"Leukemia"},{"key":"1714_CR8","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1097\/HS9.0000000000000466","volume":"4","author":"M Huguet","year":"2020","unstructured":"Huguet\u00a0M, Zamora\u00a0L, Granada\u00a0I et\u00a0al (2020) Polycythemia Vera Evolution to Chronic Myelomocytic Leukemia: The Prognostic Value of Next Generation Sequencing. Hemasphere 4:e466. https:\/\/doi.org\/10.1097\/HS9.0000000000000466","journal-title":"Hemasphere"},{"key":"1714_CR9","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury\u00a0JD, Solary\u00a0E, Abla\u00a0O et\u00a0al (2022) The 5th\u00a0edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia 36:1703\u20131719. https:\/\/doi.org\/10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"1714_CR10","volume-title":"Onkopedia Leitlinie Polyzyth\u00e4mia Vera (PV)","author":"E Lengfelder","year":"2023","unstructured":"Lengfelder\u00a0E, Baerlocher\u00a0GM, D\u00f6hner\u00a0K et\u00a0al (2023) Onkopedia Leitlinie Polyzyth\u00e4mia Vera (PV)"},{"key":"1714_CR11","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.3324\/haematol.2018.208082","volume":"104","author":"MM Patnaik","year":"2019","unstructured":"Patnaik\u00a0MM, Pophali\u00a0PA, Lasho\u00a0TL et\u00a0al (2019) Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation. Haematologica 104:e236\u2013e239. https:\/\/doi.org\/10.3324\/haematol.2018.208082","journal-title":"Haematologica"},{"key":"1714_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.leukres.2014.01.006","volume":"38","author":"L Pleyer","year":"2014","unstructured":"Pleyer\u00a0L, Germing\u00a0U, Sperr\u00a0WR et\u00a0al (2014) Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival. Leuk Res 38:475\u2013483. https:\/\/doi.org\/10.1016\/j.leukres.2014.01.006","journal-title":"Leuk Res"},{"key":"1714_CR13","doi-asserted-by":"publisher","unstructured":"Pleyer L, Leisch M, Kourakli A et\u00a0al (2021) Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a\u00a0retrospective cohort study. The Lancet Haematology 8:e135\u2013e148. https:\/\/doi.org\/10.1016\/S2352-3026(20)30374-4","DOI":"10.1016\/S2352-3026(20)30374-4"},{"key":"1714_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.mayocp.2018.08.022","volume":"94","author":"N Szuber","year":"2019","unstructured":"Szuber\u00a0N, Mudireddy\u00a0M, Nicolosi\u00a0M et\u00a0al (2019) 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups. Mayo Clin Proc 94:599\u2013610. https:\/\/doi.org\/10.1016\/j.mayocp.2018.08.022","journal-title":"Mayo Clin Proc"},{"key":"1714_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/bloodadvances.2016000216","volume":"1","author":"A Tefferi","year":"2016","unstructured":"Tefferi\u00a0A, Lasho\u00a0TL, Guglielmelli\u00a0P et\u00a0al (2016) Targeted deep sequencing in polycythemia vera and essential thrombocythemia. Blood Adv 1:21\u201330. https:\/\/doi.org\/10.1182\/bloodadvances.2016000216","journal-title":"Blood Adv"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01714-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-024-01714-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01714-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T10:02:05Z","timestamp":1728036125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-024-01714-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1714"],"URL":"https:\/\/doi.org\/10.1007\/s00108-024-01714-2","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2024,5,22]]},"assertion":[{"value":"18 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Lohneis, H.-W.\u00a0Bernd und P.\u00a0Czyborra geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}